3653 results for «203»
3653 results
Feedback from Innovator's Exchange Hub
15 May 2023 – From PCR Innovators Day 2023
Welcome introduction
15 May 2023 – From PCR Innovators Day 2023
Where will the future of Robotics in Interventional Cardiology take us?
15 May 2023 – From PCR Innovators day 2023
Innovations in Mitral and Tricuspid Valves Disease interventions
15 May 2023 – From PCR Innovators Day 2023
A word from our sponsor
15 May 2023 – From PCR Innovators Day 2023
Innovations in Heart Failure: Pumps, Remodeling and Monitoring
15 May 2023 – From PCR Innovators Day 2023
How will "Big Data" and artificial intelligence change the practice in Interventional Cardiology?
15 May 2023 – From PCR Innovators Day 2023
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023
BIOMAG-I clinical trial reaches primary endpoint at six month for unique next generation resorbable magnesium scaffold
23 Sep 2022
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial
31 Aug 2021
Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
